drugset / Trial / NCT03278444
Treatment of Advanced Hepatocellular Carcinoma
Phase 3
Unknown
300 enrolled
The First Affiliated Hospital of Zhengzhou University
Anyang Tumor Hospital · collabFirst Affiliated Hospital of Xinjiang Medical University · collabFirst People's Hospital of Shangqiu · collabLuoyang Central Hospital · collabNanyang Central Hospital · collabPingmei Shenma Medical Group General Hospital · collabThird People's Hospital of Jiaozuo · collab
RandomizedParallel-groupOpen-labelTreatment
Summary
The purpose of this study is to evaluate the efficacy and safety of arginine hydrochloride combined with trimetazidine hydrochloride tablets in the treatment of patients with hepatocellular carcinoma.
Timeline
- Start
- 2017-07-18
- Primary completion
- 2021-07
- Completion
- 2021-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | L-arginine | Small molecule | 5 g | Intravenous |
| Subject | Trimetazidine | Small molecule | 40 mg | — |